Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Géraldine Cohuet
Observed names:
G Cohuet,
G. Cohuet,
Geraldine Cohuet,
Géraldine M. S. Cohuet,
Géraldine M.S. Cohuet
Institution:
Chiesi (France)
Observed institutions:
Inserm,
Maastricht University,
Heart Foundation,
Chiesi (Italy),
Hôpital Broussais,
Université Pierre-et-Marie-Curie,
Chiesi (France),
Universidad Autónoma de Madrid,
University of Glasgow
show all 9
OpenAlex ID:
A5036643439
Extrafine inhaled triple therapy versus dual bronchodilator therapy in chronic obstructive pulmonary disease (TRIBUTE): a double-blind, parallel group, randomised controlled trial
2018
·
Alberto Papi
, Jørgen Vestbo
, et al.
·
The Lancet
·
620
Single inhaler extrafine triple therapy versus long-acting muscarinic antagonist therapy for chronic obstructive pulmonary disease (TRINITY): a double-blind, parallel group, randomised controlled trial
2017
·
Jørgen Vestbo
, Alberto Papi
, et al.
·
The Lancet
·
433
Single inhaler triple therapy versus inhaled corticosteroid plus long-acting β2-agonist therapy for chronic obstructive pulmonary disease (TRILOGY): a double-blind, parallel group, randomised controlled trial
2016
·
Dave Singh
, Alberto Papi
, et al.
·
The Lancet
·
431
PDF
Mechanisms of target organ damage caused by hypertension: Therapeutic potential
2005
·
G. Cohuet
, H. Struijker-Boudier
·
Pharmacology & Therapeutics
·
162
Extrafine beclomethasone/formoterol in severe COPD patients with history of exacerbations
2014
·
J.A. Wedzicha
, D. Singh
, et al.
·
Respiratory Medicine
·
107
PDF
Mechanical properties and structure of carotid arteries in mice lacking desmin
2001
·
Patrick Lacolley
, Pascal Challande
, et al.
·
Cardiovascular Research
·
78
The heart, macrocirculation and microcirculation in hypertension: a unifying hypothesis
2003
·
Harry A.J. Struijker Boudier
, Géraldine M.S. Cohuet
, et al.
·
Journal of Hypertension
·
54
Mechanical Strength of the Isolated Carotid Artery in SHR
2001
·
Geraldine Cohuet
, Pascal Challande
, et al.
·
Hypertension
·
36
A trial of beclomethasone/formoterol in COPD using EXACT-PRO to measure exacerbations
2012
·
Dave Singh
, Jorg Kampschulte
, et al.
·
European Respiratory Journal
·
29
PDF
Fadrozole Reverses Cardiac Fibrosis in Spontaneously Hypertensive Heart Failure Rats: Discordant Enantioselectivity Versus Reduction of Plasma Aldosterone
2007
·
Monica Minnaard-Huiban
, Judith M. A. Emmen
, et al.
·
Endocrinology
·
25
The bronchodilator effects of extrafine glycopyrronium added to combination treatment with beclometasone dipropionate plus formoterol in COPD: A randomised crossover study (the TRIDENT study)
2016
·
Dave Singh
, Winfried Schröder-Babo
, et al.
·
Respiratory Medicine
·
24
PDF
Corrigendum to “Extrafine beclomethasone/formoterol in severe COPD patients with history of exacerbations” [Respir Med 108 (2014) 1153–1162]
2015
·
J.A. Wedzicha
, D. Singh
, et al.
·
Respiratory Medicine
·
13
PDF
Efficacy and Safety of CHF6001, A Novel Inhaled PDE4 Inhibitor in COPD: The Pioneer Dose Finding Study
2019
·
D. Singh
, M.A. Nandeuil
, et al.
·
American Journal of Respiratory and Critical Care Medicine
·
3
FORWARD: A study of extrafine beclomethasone/formoterol compared with formoterol alone in patients with severe COPD and a history of exacerbations
2013
·
Alvar Agusti
, Massimo Corradi
, et al.
·
European Respiratory Journal
·
2
Reduction in fatal events with extrafine inhaled corticosteroid (ICS)-containing medications: results of stratified safety pooled analysis of the TRILOGY, TRINITY and TRIBUTE studies.
2018
·
Leonardo Fabbri
, Dave Singh
, et al.
·
European Respiratory Journal
·
1
P276 Cardiovascular safety of extrafine single inhaler triple combination of beclometasone dipropionate, formoterol fumarate, and glycopyrronium bromide in copd: results of safety analysis from the trilogy and trinity studies
2017
·
M Scuri
, D Singh
, et al.
·
Thorax
·
1
PDF
P273 Association of incident pneumonia and exacerbations with extrafine triple therapy in one single inhaler in copd patients: a post-hoc analysis from trilogy and trinity studies
2017
·
M Scuri
, J Vestbo
, et al.
·
Thorax
·
1
PDF
P271 Effect of extrafine single inhaler triple therapy on lung function and use of rescue medication: results from the trinity study
2017
·
M Scuri
, J Vestbo
, et al.
·
Thorax
·
1
PDF
LATE-BREAKING ABSTRACT: Association of incident pneumonia and exacerbations with extrafine beclometasone dipropionate/formoterol (BDP/FF) in severe COPD patients: A post-hoc analysis of FORWARD study
2016
·
Massimo Corradi
, Monica Spinola
, et al.
·
European Respiratory Journal
·
1
Patterns of symptom change measured using the EXACT diary associated with prescription of corticosteroids or antibiotics in COPD exacerbations
2015
·
Stefano Vezzoli
, Paul Jones
, et al.
·
European Respiratory Journal
·
1
Improvement of Microcirculatory Damage
2004
·
H. A.J. Struijker Boudier
, G. Cohuet
, et al.
·
Journal of Hypertension
·
1
Étude de recherche de dose PIONEER : efficacité et tolérance du CHF6001, un nouvel inhibiteur de PDE4 par voie inhalée
2020
·
D. Singh
, M.A. Nandeuil
, et al.
·
Revue des Maladies Respiratoires Actualités
Single Inhaler Extrafine Triple Therapy improves Quality of Life in COPD Patients compared to Indacaterol/Glycopyrronium: Post-hoc Analysis of the TRIBUTE study
2019
·
M Scuri
, D Singh
, et al.
·
Pneumologie
Reduction in fatal events with extrafine inhaled corticosteroid (ICS)-containing medications: Results of stratified safety pooled analysis of the TRILOGY, TRINITY and TRIBUTE studies
2019
·
LM Fabbri
, D Singh
, et al.
·
Pneumologie
Association of Incident Pneumonia and Exacerbations with Extrafine Triple Therapy in One Single Inhaler in COPD
2018
·
M Scuri
, J Vestbo
, et al.
·
Pneumologie
Show more works
View as search
Works count:
33
Citation count:
2,024
H-index:
12
I10-index:
12
Year
Topic
Type
